Editorial: New treatment strategies in schizophrenia beyond dopamine: glutamatergic neurotransmission and more.
Standard
Editorial: New treatment strategies in schizophrenia beyond dopamine: glutamatergic neurotransmission and more. / Mulert, Christoph; Scarr, E.
in: CURR PHARM BIOTECHNO, Jahrgang 13, Nr. 8, 8, 2012, S. 1474-1475.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Editorial: New treatment strategies in schizophrenia beyond dopamine: glutamatergic neurotransmission and more.
AU - Mulert, Christoph
AU - Scarr, E
PY - 2012
Y1 - 2012
KW - Synaptic Transmission
KW - Antipsychotic Agents/therapeutic use
KW - Schizophrenia/physiopathology/therapy
KW - Dopamine
KW - Receptors, Glutamate/physiology
KW - Synaptic Transmission
KW - Antipsychotic Agents/therapeutic use
KW - Schizophrenia/physiopathology/therapy
KW - Dopamine
KW - Receptors, Glutamate/physiology
M3 - SCORING: Journal article
VL - 13
SP - 1474
EP - 1475
JO - CURR PHARM BIOTECHNO
JF - CURR PHARM BIOTECHNO
SN - 1389-2010
IS - 8
M1 - 8
ER -